Mark DG, Huang J, Kennedy CJ, et al. - Researchers investigated residual 60-day major adverse cardiac events (MACE) risks among patients with non-low modified History, Electrocardiogram, Age, Risk factors and Troponin (HEART) scores. They performed secondary analysis of a retrospective cohort of 22,976 ED patients who presented with chest pain to an integrated healthcare system between 2013 and 2015. Among these patients, 13,521 (59%) had non-low (≥ 4) modified HEART scores. Sixty-day MACE risk of 2.0% was observed among non-low HEART score patients. The risk was 4.4% following inclusion of all coronary revascularizations (MACE-R). Relative to the original HEART score validation studies, patients with non-low modified HEART scores (excluding those with abnormal troponin or ischemic ECGs) appear to have much lower risk of near-term MACE.